Methods of treating non-syndromic sensorineural hearing loss
US12226493B2 · kind B2 · utility
0Cited by
12References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2019 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | May 23, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of a stereocilin protein, and the use of these compositions to treat non-syndromic sensorineural hearing loss in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.